Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-10-26

Clinical Trial Update: Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating single versus multi-dose oral tranexamic acid in high-risk patients for blood transfusion after total joint arthroplasty has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Rush University Medical Center | Conditions: Anemia, Arthritis | Phase 4 | Status: WITHDRAWN